Roy D. Baynes Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Roy D. Baynes is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 43,500 shares of ATRA, which is worth approximately $498,945. The most recent transaction as insider was on Jun 23, 2022, when has been sold 20,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.5K
0% 3M change
0% 12M change
Total Value Held $498,945

Roy D. Baynes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2022
BUY
Grant, award, or other acquisition
-
20,500 Added 32.03%
43,500 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 32.35%
23,000 Common Stock

Also insider at

TVTX
Travere Therapeutics, Inc. Healthcare
NTRA
Natera, Inc. Healthcare
RDB

Roy D. Baynes

Austin, TX

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA